S100A8 and colitis: To demonstrate the causal relationship between S100a8/9 levels and the exacerbated colitis phenotype in Dok3−/− mice, we treated WT and Dok3−/− mice with the RAGE antagonist FPS-ZM1, which can inhibit the function of S100a8/9 by blocking their binding to the RAGE receptor [33].